Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study

2014/11/07 by Eva Van Caenegem, E. Van Caenegem, K. Wierckx +13 · 1 voice · 1 citation
Medicine · Psychology · #Bone health and osteoporosis research #LGBTQ Health, Identity, and Policy #Menopause: Health Impacts and Treatments

paper · doi:10.1007/s00198-014-2805-3

crossref issued 2014/11/07 · crossref published 2014/11/07 · crossref published-online 2014/11/07 · openalex publication_date 2014/11/07 · crossref created 2014/11/14 · crossref published-print 2015/01/01 · crossref deposited 2019/08/17 · openalex created_date 2025/10/10 · crossref indexed 2026/06/06 · openalex updated_date 2026/08/04

Cited by

• Oestrogen and anti-androgen therapy for transgender women

Discussions

• ... lower baseline than cis men*. Pre-hormone therapy. This has been found by multiple studies: doi.org/10.1007/s001... doi.org/10.1016/j.yh... 6.4%–8.0% lower bone mineral density, 6,0-11,4% lower [bsky, 0 points, 1 comments]